Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

We've got all the details about who's eligible for the massive 23andMe data breach settlement and how to make a claim -- plus, who might be able to get as much as $10,000.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both companies Both companies vowed that Regeneron is committed to comply with 23andMe's privacy policies,